Just a moment...

Top
FeedbackReport
×

By creating an account you can:

Logo TaxTMI
>
Feedback/Report an Error
Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
Make Most of Text Search
  1. Checkout this video tutorial: How to search effectively on TaxTMI.
  2. Put words in double quotes for exact word search, eg: "income tax"
  3. Avoid noise words such as : 'and, of, the, a'
  4. Sort by Relevance to get the most relevant document.
  5. Press Enter to add multiple terms/multiple phrases, and then click on Search to Search.
  6. Text Search
  7. The system will try to fetch results that contains ALL your words.
  8. Once you add keywords, you'll see a new 'Search In' filter that makes your results even more precise.
  9. Text Search
Add to...
You have not created any category. Kindly create one to bookmark this item!
Create New Category
Hide
Title :
Description :
❮❮ Hide
Expand ❯❯
Close ✕
🔎 News - Adv. Search
TEXT SEARCH:

Press 'Enter' to add multiple search terms. Rules for Better Search

Search In:
Main Text + AI Text
  • Main Text
  • Main Text + AI Text
  • AI Text
Category: ?
Categorized by AI
---- All Categories ----
  • ---- All Categories ----
  • Income Tax
  • GST
  • Customs, DGFT & SEZ
  • FEMA & RBI
  • Corp. Laws, SEBI & IBC
  • PMLA, Black Money & ED
  • Budget
  • News and Press Release
  • PTI News
Month:
---- All Months ----
  • ---- All Months ----
  • January
  • February
  • March
  • April
  • May
  • June
  • July
  • August
  • September
  • October
  • November
  • December
Year:
---- All Years ----
  • ---- All Years ----
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
    Markets trade higher in early trade amid fresh foreign fund inflows, rally in US peers
    Rupee rises 8 paise to 87.50 against US dollar in early trade
    Pak Army chief Munir repeats anti-India rhetoric in US
    Secretary Expenditure Shri V. Vualnam presides over the Foundation Day celebration of Indian Cost Accounts Service (ICoAS) Day 2025 in New Delhi
    Trump yet to decide on tariffs over China’s Russian oil purchase: Vance
    Kalyan civic body's order for closure of meat shops on Independence Day sparks row
    Important cases listed in Supreme Court on Monday
    Centre's advertising budget up by 84% since 2020-21: TMC quotes official data
    Netanyahu defends new military offensive in Gaza and says it will be wider than announced
    Netanyahu defends new military offensive in Gaza, says it will be wider than announced
    UP: 19-year-old man arrested for kidnapping, raping, forcing Hindu girl to convert
    Delhi-bound Air India flight gets diverted to Chennai after snag
    Row over Kalyan civic body ordering closure of meat shops on Independence Day
    Jammu: Top bosses of Hyderabad-based company booked for fraud with Falcon app
    Robert Vadra gave evasive replies, put onus on deceased associates: ED chargesheet in Gurugram land deal case
    Man posing as IAS officer arrested in Gurugram
    Netanyahu defends planned military offensive in Gaza, lashes out at 'global campaign of lies'
    India fastest growing economy in world, says PM Modi
    Noida: 6 held for duping people by posing as members of international police organisations, say officials
    CCI orders probe against RCF for unfair sale of products with urea in Maharashtra

Are you sure you want to delete "My most important" ?

NOTE:

News

Back

All News

Showing Results for : Category : All
Reset Filters
Showing
Records
ExpandCollapse

    News

    Back

    All News

    Showing Results for : Category : AllReset Filters
    Case ID :

    CCI approves acquisition of minority stake of BDR Pharmaceuticals International Private Limited by Multiples Private Equity Fund III, SRF Transnational Holdings Limited, Balkrishna Industries Limited, Dharmayug Investments Limited, QRG Investments and Holdings Limited, Mr. Nishant K. Agarwal and Ms. Mallika Srinivasan

    April 18, 2022

    📋
    Contents
    Summary
    Note

    Note

    Note

    Bookmark

    print

    Print

    The Competition Commission of India (CCI) approves acquisition of minority stake of BDR Pharmaceuticals International Private Limited (BDR/Target) by Multiples Private Equity Fund III, SRF Transnational Holdings Limited (SRF Transnational), Balkrishna Industries Limited (BIL), Dharmayug Investments Limited (DIL), QRG Investments and Holdings Limited (QRG), Mr. Nishant K. Agarwal and Ms. Mallika Srinivasan (Acquirers).

    SRF Transnational, BIL, DIL, QRG, Mr. Agarwal, and Ms. Srinivasan are collectively referred to as the ‘Financial Investors’. The Multiples Fund III, Financial Investors and the Target are collectively referred to as the ‘Parties’.

    The proposed combination relates to acquisition of minority stake by Multiples Fund III and Financial Investors in the Target. The acquisition of equity shares of the Target and falls under Section 5(a) of the Competition Act, 2002. A brief description of the Parties is provided below:

    Multiples Fund IIIMultiples Fund III is a Category II Alternative Investment Fund with the Securities and Exchange Board of India and is being managed by Multiples Alternate Asset Management Private Limited. It belongs to the Multiples group, which, through its portfolio companies, is directly or indirectly engaged in sectors including film exhibition, financial services, banking, etc. in India.

    SRF Transnational: It is a non-banking financial company (NBFC) registered with the Reserve Bank of India (RBI). It is engaged in the business of investment in securities of other companies. 

    BIL:  It is engaged in the business of manufacturing and selling of off-highway tyres.

    DILIt is an NBFC registered with the RBI.

    QRGIt is an NBFC registered with the RBI and holds investments in several companies. 

    Mr. Nishant K. AgarwalHe is an independent investor.

    Ms. Mallika Srinivasan: She is an independent investor.

    BDRIt is a pharmaceutical company specialised in four therapeutic segments i.e., oncology, critical care, gynecology, and neurology. It is engaged in business of: (i) manufacture and sale of active pharmaceutical ingredients; (ii) manufacture and sale of formulations; and (iii) contract development and manufacturing services.

    Detailed order of the CCI will follow.

    Topics

    ActsIncome Tax